CRP and chronic kidney disease: Additionally, those with higher DII had higher CRP [Q1: 0.37(0.02) vs. Q2: 0.48(0.04) vs. Q3: 0.47(0.03) vs. Q4: 0.60(0.03), p < 0.001] and a higher prevalence of DM [Q1: 15.1% vs. Q2: 16.4% vs. Q3: 17.9% vs. Q4: 20.8%, p = 0.005], CKD [Q1: 15.4% vs. Q2: 18.8% vs. Q3: 19.2% vs. Q4: 20.0%, p = 0.003], and CVD [Q1: 10.9% vs. Q2: 12.7% vs. Q3: 13.4% vs. Q4: 15.1%, p = 0.009].